Improved in vitro permeation of nabumetone across rat skin from 1-O-alkylglycerol/lecithin stabilized o/w nanoemulsions

Journal of Dispersion Science and Technology

Volumn 27, Issue 7, 2006, Pages 921-926

  Madhusudhan, B ^a   Rambhau, D ^a   Apte, S S ^a   Gopinath, D ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

1 O alkylglycerols; Nabumetone; Nanoemulsions; Skin permeation

Indexed keywords

EXTRACTION; GLYCEROL; LIPIDS; OILS AND FATS; SKIN;

ALKYLGLYCEROLS; NABUMETONE; NANOEMULSIONS; SKIN PERMEATION;

EMULSIONS;

EMULSIONS; EXTRACTION; GLYCEROL; LIPIDS; OILS AND FATS; SKIN;

EID: 33746584002     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932690600766199     Document Type: Article

References (24)

1. Schwarz, J. and Weisspapir, M. and Friedman, D. (1995) Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams Pharm. Res., 12, pp. 687-692.
2. Youenang Piemi, M. and Korner, D. and Benita, S. and Jean-Paul, M. (1999) Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs J. Control. Release, 58, pp. 177-187.
3. Fernandez, C. and Marti-Mestres, G. and Ramos, J. and Maillols, H. (2000) LC analysis of benzophenone-3 II: Application to determination in vitro and in vivo skin penetration from solvents, coarse and submicron emulsions J. Pharm. Biomed. Anal., 24, pp. 155-165.
4. Fang, J. and Leu, Y. and Chang, C. and Lin, C. and Tsai, Y. (2004) Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery Drug Deliv., 11, pp. 97-105.
5. Ved, H. and Gustow, E. and Mahadevan, V. and Pieringer, R. (1984) Dodecylglycerol: A new type of antibacterial agent which stimulates autolysin activity in Streptococcus faecium ATCC 9790 J. Biol. Chem., 259, pp. 8115-8121.
6. Brissette, J. and Cabacungan, E. and Peiringer, R. (1986) Studies on the antibacterial activity of dodecylglycerol: Its limited metabolism and inhibition of glycerolipid and lipoteichoic acid biosynthesis in Streptococcus mutans BHT J. Biol. Chem., 261, pp. 6338-6345.
7. Hallgren, B. and Stallberg, G. and Boerd, B. (1978) Occurrence, synthesis of biological effects of substituted glycerol ethers Prog. Chem. Fats Lipids, 16, pp. 45-58.
8. Erdlenbruch, B. and Jendrossek, V. and Eibl, H. and Lakomek, M. (2000) Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats Exp. Brain Res., 135, pp. 417-422.
9. Heyneman, C. and Lawless-Liday, C. and Wall, G. (2000) Oral versus topical NSAIDs in rheumatic diseases: A comparison Drugs, 60, pp. 555-574.
10. Honeywell-Nguyen, P. and Bouwstra, J. (2003) The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: A suggested mechanism of action J. Control. Release, 86, pp. 145-156.
11. Touitou, E. and Dayan, N. and Bergelson, L. and Godin, B. and Eliaz, M. (2000) Ethosomes - Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties J. Control. Release, 65, pp. 403-418.
12. El Maghraby, G. and Adrian, C. and Brian, W. (2000) Skin delivery of oestradiol from lipid vesicles: Importance of liposome structure Int. J. Pharm., 204, pp. 159-169.
13. Gregor, C. (1996) Transfersomes, liposomes and other lipid suspensions on the skin: Penetration enhancement, vesicle penetration and transdermal drug delivery Crit. Rev. Ther. Drug Carrier Syst., 13, pp. 257-388.
14. Hwang, B. and Jung, B. and Chung, S. and Lee, M. and Shim, C. (1997) In vitro skin permeation of nicotine from proliposomes J. Control. Release, 49, pp. 177-184.
15. Alsarra, I. and Bosela, A. and Ahmed, S. and Mahrous, G. (2005) Proniosomes as a drug carrier for transdermal delivery of ketorolac Eur. J. Pharm. Biopharm., 59, pp. 485-490.
16. Fang, J. and Yu, S. and Wu, P. and Huang, Y. and Tsai, Y. (2001) In vitro skin permeation of estradiol from various proniosome formulations Int. J. Pharm., 215, pp. 91-99.
17. Cappel, M. and Kreuter, J. (1991) Effect of nanoparticles on transdermal drug delivery J. Microencapsulation, 8, pp. 369-374.
18. Roberts II, L. and Morrow, J.(2001) Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Goodman and Gilman's the Pharmacological Basis of Therapeutics10th ed. (pp. 687-731). New York: McGraw-Hill.
19. Baumann, W. and Mangold, H. (1964) Reactions of aliphatic methanesulfonates I: Syntheses of long-chain glycerol-(1) ethers J. Org. Chem., 29, pp. 3055-3057.
20. Benita, S. and Levy, M. (1993) Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization J. Pharm. Sci., 82, pp. 1069-1079.
21. Unger, C. and Eibl, H. and von Heyden, H. and Krisch, B. and Nagel, G. (1985) Blut-Hirnschranke und Penetration von Zytostatika Klin. Wochenschr., 63, pp. 565-571.
22. Walters, K. and Walkers, M. and Olejnik, O. (1988) Nonionic surfactant effect on hairless mouseskin permeability characteristics J. Pharm. Pharmacol., 40, pp. 525-529.
23. Williams, A. and Barry, B. (2004) Penetration enhancers Adv. Drug Deliv. Rev., 56, pp. 603-618.
24. Vaddi, H. and Ho, P. and Chan, Y. and Chan, S. (2002) Terpenes in ethanol: Haloperidol permeation and partition through human skin and stratum corneum changes J. Control. Release, 81, pp. 121-133.